Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces that the first patient in the United States (U.S.) has been dosed in BiPASS™ (Biopsy of the Prostate Avoidance ...
Learn about the science of sewer odors, including detection techniques and control solutions such as chemical injection, ...
Results of the SPACE trial demonstrating the safety and efficacy of subcutaneous fremanezumab for the prevention of pediatric ...
Amgen's research chief said the company is very confident about its experimental obesity drug MariTide, as it prepares on ...
Doctors explain why blunders persist, lawyers say negligence actionable  |  One in every 10 patients harmed while receiving ...
Fiscal policy is the dominant market driver into 2025–26, but liquidity momentum is fading, raising volatility and downside ...
This article was reviewed by Kelly Brown MD, MBA. Would you inject your own blood into your privates if it meant better ...
St Bartholomew's Hospital and The James Cook University Hospital mark key UK expansion of the company's Phase 2 mCRPC ...
Ocugen has announced positive preliminary 12-month data from its phase 2 ArMaDa trial evaluating OCU410 (AAV5-RORA) for the ...
Eli Lilly's research and development head said on Monday the company will have plenty of supply to launch its ...
A Westminster resident said it cost $1,300 for a repair shop to clean his truck’s gas tank and fuel line after he purchased ...
Precigen, Inc. ( PGEN) 44th Annual J.P. Morgan Healthcare Conference January 15, 2026 10:30 AM EST ...